Suppr超能文献

癌症相关性血栓形成的小鼠模型。

Mouse models of cancer-associated thrombosis.

机构信息

Department of Medicine, Division of Hematology and Oncology, Thrombosis and Hemostasis Program, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA; K. G. Jebsen Thrombosis Research and Expertise Center, University of Tromsø, Tromsø, Norway.

Department of Medicine, Division of Hematology and Oncology, Thrombosis and Hemostasis Program, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA; Department of Pathology and Laboratory Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

出版信息

Thromb Res. 2018 Apr;164 Suppl 1(Suppl 1):S48-S53. doi: 10.1016/j.thromres.2017.12.018. Epub 2017 Dec 29.

Abstract

Cancer patients have an increased risk of venous thromboembolism (VTE) compared with the general population. Mouse models are used to better understand the mechanisms of cancer-associated thrombosis. Several mouse models of cancer-associated thrombosis have been developed that use different mouse strains, tumors, tumor sites and thrombosis models. In this review, we summarize these different models. These models have been used to determine the role of different pathways in cancer-associated thrombosis. For instance, they have revealed roles for tumor-derived tissue factor-positive microvesicles and neutrophil extracellular traps in thrombosis in tumor-bearing mice. A better understanding of the mechanisms of cancer-associated thrombosis may allow the development of new therapies to reduce thrombosis in cancer patients.

摘要

癌症患者发生静脉血栓栓塞症(venous thromboembolism,VTE)的风险高于普通人群。人们使用小鼠模型来更好地理解与癌症相关的血栓形成机制。目前已经开发出多种与癌症相关的血栓形成小鼠模型,这些模型使用了不同的小鼠品系、肿瘤、肿瘤部位和血栓形成模型。在这篇综述中,我们对这些不同的模型进行了总结。这些模型被用于确定不同通路在与癌症相关的血栓形成中的作用。例如,它们揭示了肿瘤来源的组织因子阳性微囊泡和中性粒细胞胞外诱捕网在荷瘤小鼠血栓形成中的作用。更好地理解与癌症相关的血栓形成机制可能会促进开发新的治疗方法,以减少癌症患者的血栓形成。

相似文献

1
Mouse models of cancer-associated thrombosis.
Thromb Res. 2018 Apr;164 Suppl 1(Suppl 1):S48-S53. doi: 10.1016/j.thromres.2017.12.018. Epub 2017 Dec 29.
2
Venous thrombosis and cancer: from mouse models to clinical trials.
J Thromb Haemost. 2015 Aug;13(8):1372-82. doi: 10.1111/jth.13009. Epub 2015 Jun 26.
3
Update from the laboratory: mechanistic studies of pathways of cancer-associated venous thrombosis using mouse models.
Hematology Am Soc Hematol Educ Program. 2019 Dec 6;2019(1):182-186. doi: 10.1182/hematology.2019000025.
4
Microparticles and cancer thrombosis in animal models.
Thromb Res. 2016 Apr;140 Suppl 1:S21-6. doi: 10.1016/S0049-3848(16)30094-9.
5
Flamethrowers: blood cells and cancer thrombosis risk.
Hematology Am Soc Hematol Educ Program. 2014 Dec 5;2014(1):410-7. doi: 10.1182/asheducation-2014.1.410. Epub 2014 Nov 18.
7
Cancer-associated pathways and biomarkers of venous thrombosis.
Blood. 2017 Sep 28;130(13):1499-1506. doi: 10.1182/blood-2017-03-743211. Epub 2017 Aug 14.
8
Deep venous thrombosis.
Hematology Am Soc Hematol Educ Program. 2004:439-56. doi: 10.1182/asheducation-2004.1.439.
10
The role of podoplanin in cancer-associated thrombosis.
Thromb Res. 2018 Apr;164 Suppl 1:S34-S39. doi: 10.1016/j.thromres.2018.01.020.

引用本文的文献

1
Modeling cancer-associated hypercoagulability using glioblastoma spheroids in microfluidic chips.
Res Pract Thromb Haemost. 2024 Jun 17;8(5):102475. doi: 10.1016/j.rpth.2024.102475. eCollection 2024 Jul.
2
The unfolded protein response links ER stress to cancer-associated thrombosis.
JCI Insight. 2023 Aug 31;8(19):e170148. doi: 10.1172/jci.insight.170148.
3
Tissue factor activates the coagulation cascade in mouse models of acute promyelocytic leukemia.
Blood Adv. 2023 Sep 26;7(18):5458-5469. doi: 10.1182/bloodadvances.2023010466.
5
Mechanisms of cancer-associated thrombosis.
Res Pract Thromb Haemost. 2023 Mar 15;7(3):100123. doi: 10.1016/j.rpth.2023.100123. eCollection 2023 Mar.
6
Decreased Platelet Reactivity and Function in a Mouse Model of Human Pancreatic Cancer.
Thromb Haemost. 2023 May;123(5):501-509. doi: 10.1055/s-0043-1761419. Epub 2023 Jan 30.
7
Establishment of a mouse model for ovarian cancer-associated venous thromboembolism.
Exp Biol Med (Maywood). 2023 Jan;248(1):26-35. doi: 10.1177/15353702221118533. Epub 2022 Aug 29.
8
P2RY12-Inhibitors Reduce Cancer-Associated Thrombosis and Tumor Growth in Pancreatic Cancers.
Front Oncol. 2021 Sep 13;11:704945. doi: 10.3389/fonc.2021.704945. eCollection 2021.
9
The D-dimer level predicts the prognosis in patients with lung cancer: a systematic review and meta-analysis.
J Cardiothorac Surg. 2021 Aug 28;16(1):243. doi: 10.1186/s13019-021-01618-4.
10
Tissue Factor and Extracellular Vesicles: Activation of Coagulation and Impact on Survival in Cancer.
Cancers (Basel). 2021 Jul 30;13(15):3839. doi: 10.3390/cancers13153839.

本文引用的文献

2
Human pancreatic tumors grown in mice release tissue factor-positive microvesicles that increase venous clot size.
J Thromb Haemost. 2017 Nov;15(11):2208-2217. doi: 10.1111/jth.13809. Epub 2017 Sep 20.
3
Cancer-associated pathways and biomarkers of venous thrombosis.
Blood. 2017 Sep 28;130(13):1499-1506. doi: 10.1182/blood-2017-03-743211. Epub 2017 Aug 14.
5
Evaluation of venous thrombosis and tissue factor in epithelial ovarian cancer.
Gynecol Oncol. 2017 Jul;146(1):146-152. doi: 10.1016/j.ygyno.2017.04.021. Epub 2017 May 10.
6
Mice with a deficiency in CLEC-2 are protected against deep vein thrombosis.
Blood. 2017 Apr 6;129(14):2013-2020. doi: 10.1182/blood-2016-09-742999. Epub 2017 Jan 19.
7
Prostaglandin E synthase is upregulated by Gas6 during cancer-induced venous thrombosis.
Blood. 2016 Feb 11;127(6):769-77. doi: 10.1182/blood-2015-02-628867. Epub 2015 Nov 19.
8
Tissue factor-positive tumor microvesicles activate platelets and enhance thrombosis in mice.
J Thromb Haemost. 2016 Jan;14(1):153-66. doi: 10.1111/jth.13181. Epub 2015 Dec 11.
9
Intact Toll-like receptor 9 signaling in neutrophils modulates normal thrombogenesis in mice.
J Vasc Surg. 2016 Nov;64(5):1450-1458.e1. doi: 10.1016/j.jvs.2015.08.070. Epub 2015 Oct 23.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验